194 related articles for article (PubMed ID: 37851814)
1. Global lactylome reveals lactylation-dependent mechanisms underlying T
Fan W; Wang X; Zeng S; Li N; Wang G; Li R; He S; Li W; Huang J; Li X; Liu J; Hou S
Sci Adv; 2023 Oct; 9(42):eadh4655. PubMed ID: 37851814
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.
Wu S; Ma R; Zhong Y; Chen Z; Zhou H; Zhou M; Chong W; Chen J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299138
[TBL] [Abstract][Full Text] [Related]
3. miR-182-5p inhibits the pathogenic Th17 response in experimental autoimmune uveitis mice via suppressing TAF15.
Zhang L; Sun P; Zhang Y; Xu Y; Sun Y
Biochem Biophys Res Commun; 2020 Aug; 529(3):784-792. PubMed ID: 32736708
[TBL] [Abstract][Full Text] [Related]
4. Activation of the Notch signaling pathway disturbs the CD4
Yin X; Liu B; Wei H; Wu S; Guo L; Xu F; Liu T; Bi H; Guo D
Inflamm Res; 2019 Sep; 68(9):761-774. PubMed ID: 31209505
[TBL] [Abstract][Full Text] [Related]
5. YY1 Lactylation Aggravates Autoimmune Uveitis by Enhancing Microglial Functions via Inflammatory Genes.
Huang J; Wang X; Li N; Fan W; Li X; Zhou Q; Liu J; Li W; Zhang Z; Liu X; Zeng S; Yang H; Tian M; Yang P; Hou S
Adv Sci (Weinh); 2024 May; 11(19):e2308031. PubMed ID: 38493498
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses.
Sakoda Y; Nagai T; Murata S; Mizuno Y; Kurosawa H; Shoda H; Morishige N; Yanai R; Sonoda KH; Tamada K
J Immunol; 2016 Apr; 196(7):2947-54. PubMed ID: 26912321
[TBL] [Abstract][Full Text] [Related]
7. STAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis.
Escobar T; Yu CR; Muljo SA; Egwuagu CE
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4017-25. PubMed ID: 23674757
[TBL] [Abstract][Full Text] [Related]
8. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis.
Yu CR; Lee YS; Mahdi RM; Surendran N; Egwuagu CE
PLoS One; 2012; 7(1):e29742. PubMed ID: 22238646
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.
Sugita S; Kawazoe Y; Imai A; Yamada Y; Horie S; Mochizuki M
Arthritis Res Ther; 2012 May; 14(3):R99. PubMed ID: 22546542
[TBL] [Abstract][Full Text] [Related]
11. Overexpressing Kallistatin Aggravates Experimental Autoimmune Uveitis Through Promoting Th17 Differentiation.
Chen N; Chen S; Zhang Z; Cui X; Wu L; Guo K; Shao H; Ma JX; Zhang X
Front Immunol; 2021; 12():756423. PubMed ID: 34733288
[TBL] [Abstract][Full Text] [Related]
12. AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells.
Bing SJ; Shemesh I; Chong WP; Horai R; Jittayasothorn Y; Silver PB; Sredni B; Caspi RR
J Autoimmun; 2019 Jun; 100():52-61. PubMed ID: 30853312
[TBL] [Abstract][Full Text] [Related]
13. Progesterone attenuates Th17-cell pathogenicity in autoimmune uveitis via Id2/Pim1 axis.
Liu X; Gu C; Lv J; Jiang Q; Ding W; Huang Z; Liu Y; Su Y; Zhang C; Xu Z; Wang X; Su W
J Neuroinflammation; 2023 Jun; 20(1):144. PubMed ID: 37344856
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of Rbpj attenuates experimental autoimmune uveoretinitis by inhibiting IL-22-producing CD4+ T cells.
Bhuyan ZA; Asanoma M; Iwata A; Ishifune C; Maekawa Y; Shimada M; Yasutomo K
PLoS One; 2014; 9(2):e89266. PubMed ID: 24586644
[TBL] [Abstract][Full Text] [Related]
15. Sodium butyrate regulates Th17/Treg cell balance to ameliorate uveitis via the Nrf2/HO-1 pathway.
Chen X; Su W; Wan T; Yu J; Zhu W; Tang F; Liu G; Olsen N; Liang D; Zheng SG
Biochem Pharmacol; 2017 Oct; 142():111-119. PubMed ID: 28684304
[TBL] [Abstract][Full Text] [Related]
16. [Regulation of antigen specific Th17 cells differentiation in experimental autoimmune uveitis].
Chen HT; Wang H; Zhao M; Hou B
Zhonghua Yan Ke Za Zhi; 2012 Mar; 48(3):234-40. PubMed ID: 22800421
[TBL] [Abstract][Full Text] [Related]
17. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
[TBL] [Abstract][Full Text] [Related]
18. SOCS3 deletion in T lymphocytes suppresses development of chronic ocular inflammation via upregulation of CTLA-4 and expansion of regulatory T cells.
Yu CR; Kim SH; Mahdi RM; Egwuagu CE
J Immunol; 2013 Nov; 191(10):5036-43. PubMed ID: 24101549
[TBL] [Abstract][Full Text] [Related]
19. Activation of liver X receptor alleviates ocular inflammation in experimental autoimmune uveitis.
Yang H; Zheng S; Qiu Y; Yang Y; Wang C; Yang P; Li Q; Lei B
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2795-804. PubMed ID: 24699378
[TBL] [Abstract][Full Text] [Related]
20. miR-223-3p promotes autoreactive T
Wei Y; Chen S; Sun D; Li X; Wei R; Li X; Nian H
FASEB J; 2019 Dec; 33(12):13951-13965. PubMed ID: 31645142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
